Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03774784
Recruitment Status : Terminated (The study was terminated due to the impacts of COVID-19 on patient safety and enrollment.)
First Posted : December 13, 2018
Last Update Posted : June 16, 2020
Sponsor:
Information provided by (Responsible Party):
Alnylam Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : May 18, 2020
Actual Study Completion Date : May 18, 2020